ConceptMedicine
Targeted therapy
Drugs designed to block mutant proteins caused by driver mutations to control cancer.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Opens up
Concepts that name this one as a prerequisite.
Lecturers
1Lectures that assume it
5- Targeting Drug Tolerant Persister State in Lung Cancer (Yale Cancer Center Grand Rounds)
- Therapeutic Targeting of Epigenetic Mechanisms in Cancer (Yale Cancer Center Grand Rounds)
- T Cell Lifestyle in Chronic Viral Infection and Cancer: Implications for Immunotherapy
- Investigating the Complex Biology of Drug Resistance for Clinical Impact (Yale Cancer Center Grand Rounds)
- PET/MR Molecular Imaging of Cancer (Yale Cancer Center Grand Rounds)
Connections
13The lectures that define it or assume it, and the concepts next to it.
Concepts7
- Driver mutation
- Oncogene
- Acquired mutational resistance
- Antibody drug conjugate
- Drug-tolerant persister state
- Non-mutational mechanisms of resistance and persistence
Show 1 moreShow fewer
Lectures6
- RECENT ADVANCES IN TREATMENT OF STAGE I - III LUNG CANCER - DR. ASHISH SINGH - MEDICAL ONCOLOGY
- Targeting Drug Tolerant Persister State in Lung Cancer (Yale Cancer Center Grand Rounds)
- Therapeutic Targeting of Epigenetic Mechanisms in Cancer (Yale Cancer Center Grand Rounds)
- T Cell Lifestyle in Chronic Viral Infection and Cancer: Implications for Immunotherapy
- Investigating the Complex Biology of Drug Resistance for Clinical Impact (Yale Cancer Center Grand Rounds)
- PET/MR Molecular Imaging of Cancer (Yale Cancer Center Grand Rounds)